Literature DB >> 26718859

Clinical Characteristics and Outcomes of Patients With Myocardial Infarction and Cardiogenic Shock Undergoing Coronary Artery Bypass Surgery: Data From The Society of Thoracic Surgeons National Database.

Deepak Acharya1, Brian C Gulack2, Renzo Y Loyaga-Rendon3, James E Davies4, Xia He5, J Matthew Brennan6, Vinod H Thourani7, Matthew L Williams8.   

Abstract

BACKGROUND: Acute myocardial infarction complicated by cardiogenic shock (AMI-CS) is associated with substantial mortality. We evaluated outcomes of patients in The Society of Thoracic Surgeons Adult Cardiac Surgery Database who underwent coronary artery bypass graft surgery (CABG) in the setting of AMI-CS.
METHODS: All patients with AMI-CS who underwent nonelective CABG or CABG with ventricular assist device implantation within 7 days after myocardial infarction were enrolled. The primary analysis sample consisted of patients who underwent surgery between June 2011 and December 2013. Baseline characteristics, operative findings, outcomes, and the utilization of mechanical circulatory support (MCS) were assessed in detail in this population. We also evaluated trends in unadjusted mortality for all patients undergoing CABG or CABG with ventricular assist device for AMI-CS from January 2005 to December 2013.
RESULTS: A total of 5,496 patients met study criteria, comprising 1.5% of all patients undergoing CABG during the study period. Overall operative mortality was 18.7%, decreasing from 19.3% in 2005 to 18.1% in 2013 (p < 0.001). Use of MCS increased from 5.8% in 2011 to 8.8% in 2013 (p = 0.008). Patients receiving MCS had a high proportion of cardiovascular risk factors or high clinical acuity. Patients requiring preoperative and patients requiring intraoperative or postoperative MCS had operative mortality of 37.2% and 58.4%, respectively. Patients undergoing CABG as a salvage procedure had an operative mortality of 53.3%, and a high incidence of reoperation (21.8%), postoperative respiratory failure requiring prolonged ventilation (59.7%), and renal failure (18.5%).
CONCLUSIONS: Most patients undergoing CABG for AMI-CS have a sizeable but not prohibitive risk. Patients who require MCS and those undergoing operation as a salvage procedure reflect higher risk populations.
Copyright © 2016 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2015        PMID: 26718859      PMCID: PMC5142520          DOI: 10.1016/j.athoracsur.2015.10.051

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  19 in total

1.  The Society of Thoracic Surgeons: 30-day operative mortality and morbidity risk models.

Authors:  A Laurie W Shroyer; Laura P Coombs; Eric D Peterson; Mary C Eiken; Elizabeth R DeLong; Anita Chen; T Bruce Ferguson; Frederick L Grover; Fred H Edwards
Journal:  Ann Thorac Surg       Date:  2003-06       Impact factor: 4.330

2.  A decade of short-term outcomes in post cardiac surgery ventricular assist device implantation: data from the Society of Thoracic Surgeons' National Cardiac Database.

Authors:  Adrian F Hernandez; Joshua D Grab; James S Gammie; Sean M O'Brien; Bradley G Hammill; Joseph G Rogers; Margarita T Camacho; Mercedes K Dullum; T Bruce Ferguson; Eric D Peterson
Journal:  Circulation       Date:  2007-07-23       Impact factor: 29.690

3.  Important role of mechanical circulatory support in acute myocardial infarction complicated by cardiogenic shock.

Authors:  Lauren Truby; Yoshifumi Naka; Bindu Kalesan; Takeyoshi Ota; Ajay J Kirtane; Susheel Kodali; Natasha Nikic; Lily Mundy; Paolo Colombo; Ulrich P Jorde; Hiroo Takayama
Journal:  Eur J Cardiothorac Surg       Date:  2014-12-04       Impact factor: 4.191

4.  Third universal definition of myocardial infarction.

Authors:  Kristian Thygesen; Joseph S Alpert; Allan S Jaffe; Maarten L Simoons; Bernard R Chaitman; Harvey D White; Hugo A Katus; Bertil Lindahl; David A Morrow; Peter M Clemmensen; Per Johanson; Hanoch Hod; Richard Underwood; Jeroen J Bax; Robert O Bonow; Fausto Pinto; Raymond J Gibbons; Keith A Fox; Dan Atar; L Kristin Newby; Marcello Galvani; Christian W Hamm; Barry F Uretsky; Ph Gabriel Steg; William Wijns; Jean-Pierre Bassand; Phillippe Menasché; Jan Ravkilde; E Magnus Ohman; Elliott M Antman; Lars C Wallentin; Paul W Armstrong; Maarten L Simoons; James L Januzzi; Markku S Nieminen; Mihai Gheorghiade; Gerasimos Filippatos; Russell V Luepker; Stephen P Fortmann; Wayne D Rosamond; Dan Levy; David Wood; Sidney C Smith; Dayi Hu; José-Luis Lopez-Sendon; Rose Marie Robertson; Douglas Weaver; Michal Tendera; Alfred A Bove; Alexander N Parkhomenko; Elena J Vasilieva; Shanti Mendis
Journal:  Circulation       Date:  2012-08-24       Impact factor: 29.690

5.  Comparison of percutaneous coronary intervention and coronary artery bypass grafting after acute myocardial infarction complicated by cardiogenic shock: results from the Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock (SHOCK) trial.

Authors:  Harvey D White; Susan F Assmann; Timothy A Sanborn; Alice K Jacobs; John G Webb; Lynn A Sleeper; Cheuk-Kit Wong; James T Stewart; Philip E G Aylward; Shing-Chiu Wong; Judith S Hochman
Journal:  Circulation       Date:  2005-09-27       Impact factor: 29.690

6.  Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock.

Authors:  J S Hochman; L A Sleeper; J G Webb; T A Sanborn; H D White; J D Talley; C E Buller; A K Jacobs; J N Slater; J Col; S M McKinlay; T H LeJemtel
Journal:  N Engl J Med       Date:  1999-08-26       Impact factor: 91.245

7.  Intraaortic balloon support for myocardial infarction with cardiogenic shock.

Authors:  Holger Thiele; Uwe Zeymer; Franz-Josef Neumann; Miroslaw Ferenc; Hans-Georg Olbrich; Jörg Hausleiter; Gert Richardt; Marcus Hennersdorf; Klaus Empen; Georg Fuernau; Steffen Desch; Ingo Eitel; Rainer Hambrecht; Jörg Fuhrmann; Michael Böhm; Henning Ebelt; Steffen Schneider; Gerhard Schuler; Karl Werdan
Journal:  N Engl J Med       Date:  2012-08-26       Impact factor: 91.245

8.  Clinical characteristics and in-hospital outcomes of patients with cardiogenic shock undergoing coronary artery bypass surgery: insights from the Society of Thoracic Surgeons National Cardiac Database.

Authors:  Rajendra H Mehta; Joshua D Grab; Sean M O'Brien; Donald D Glower; Constance K Haan; James S Gammie; Eric D Peterson
Journal:  Circulation       Date:  2008-02-04       Impact factor: 29.690

9.  Immediate surgical coronary revascularisation in patients presenting with acute myocardial infarction.

Authors:  Nawid Khaladj; Dmitry Bobylev; Sven Peterss; Sabina Guenther; Maximilian Pichlmaier; Erik Bagaev; Andreas Martens; Malakh Shrestha; Axel Haverich; Christian Hagl
Journal:  J Cardiothorac Surg       Date:  2013-07-03       Impact factor: 1.637

10.  The current use of Impella 2.5 in acute myocardial infarction complicated by cardiogenic shock: results from the USpella Registry.

Authors:  William W O'Neill; Theodore Schreiber; David H W Wohns; Charanjit Rihal; Srihari S Naidu; Andrew B Civitello; Simon R Dixon; Joseph M Massaro; Brijeshwar Maini; E Magnus Ohman
Journal:  J Interv Cardiol       Date:  2013-12-13       Impact factor: 2.279

View more
  12 in total

1.  Coronary artery bypass grafting versus percutaneous coronary intervention for myocardial infarction complicated by cardiogenic shock.

Authors:  Nathaniel R Smilowitz; Carlos L Alviar; Stuart D Katz; Judith S Hochman
Journal:  Am Heart J       Date:  2020-03-12       Impact factor: 4.749

Review 2.  Acute Myocardial Infarction and Cardiogenic Shock Interventional Approach to Management in the Cardiac Catheterization Laboratories.

Authors:  Behnam N Tehrani; Abdulla A Damluji; Wayne B Batchelor
Journal:  Curr Cardiol Rev       Date:  2022

Review 3.  Preoperative, Multidisciplinary Clinical Optimization of Patients with Severely Depressed Left Ventricular Ejection Fraction Who Are Undergoing Coronary Artery Bypass Grafting.

Authors:  Islam Mohammad Shehata; Tiffany D Odell; Amir Elhassan; Maxim Spektor; Ivan Urits; Omar Viswanath; George M Jeha; Elyse M Cornett; Alan D Kaye
Journal:  Cardiol Ther       Date:  2020-12-23

Review 4.  Revisiting blood transfusion and predictors of outcome in cardiac surgery patients: a concise perspective.

Authors:  Carlos E Arias-Morales; Nicoleta Stoicea; Alicia A Gonzalez-Zacarias; Diana Slawski; Sujatha P Bhandary; Theodosios Saranteas; Eva Kaminiotis; Thomas J Papadimos
Journal:  F1000Res       Date:  2017-02-20

5.  Sequential organ failure assessment score predicts mortality after coronary artery bypass grafting.

Authors:  Chih-Hsiang Chang; Shao-Wei Chen; Pei-Chun Fan; Cheng-Chia Lee; Huang-Yu Yang; Su-Wei Chang; Heng-Chih Pan; Feng-Chun Tsai; Chih-Wei Yang; Yung-Chang Chen
Journal:  BMC Surg       Date:  2017-03-06       Impact factor: 2.102

6.  Peripheral blood circular RNA hsa_circ_0124644 can be used as a diagnostic biomarker of coronary artery disease.

Authors:  Zhenzhou Zhao; Xuejie Li; Chuanyu Gao; Dongdong Jian; Peiyuan Hao; Lixin Rao; Muwei Li
Journal:  Sci Rep       Date:  2017-01-03       Impact factor: 4.379

Review 7.  Predictors of Outcomes in Myocardial Infarction and Cardiogenic Shock.

Authors:  Deepak Acharya
Journal:  Cardiol Rev       Date:  2018 Sep/Oct       Impact factor: 2.644

8.  Impact of prior coronary stenting on the outcome of subsequent coronary artery bypass grafting.

Authors:  Yu-Ting Cheng; Shao-Wei Chen; Chih-Hsiang Chang; Pao-Hsien Chu; Dong-Yi Chen; Victor Chien-Chia Wu; Kuo-Sheng Liu; Yu-Yun Nan; Feng-Chun Tsai; Pyng-Jing Lin
Journal:  Biomed J       Date:  2017-05-31       Impact factor: 4.910

9.  Changes in Functional Status and Health-Related Quality of Life in Older Adults After Surgical, Interventional, or Medical Management of Acute Myocardial Infarction.

Authors:  Makoto Mori; Mia Djulbegovic; Alexandra M Hajduk; Margaret L Holland; Harlan M Krumholz; Sarwat I Chaudhry
Journal:  Semin Thorac Cardiovasc Surg       Date:  2020-05-19

10.  The interplay of LncRNA ANRIL and miR-181b on the inflammation-relevant coronary artery disease through mediating NF-κB signalling pathway.

Authors:  Feng Guo; Chengchun Tang; Yawei Li; Yuqing Liu; Ping Lv; Wei Wang; Yongyong Mu
Journal:  J Cell Mol Med       Date:  2018-08-05       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.